DEUTSCHE BANK AG\
BankPosition in LGND — Ligand Pharmaceuticals Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in LGND
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$78,899,539
+$17,784,480 QoQ
Shares Held
249,611
-18.5% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Derivatives in LGND
reported options exposure · as of Dec 31, 2021CallValue
$12,356
CallShares
128
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. LGND ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
This page
|
249,611 | $78,899,539 |
All Filings in LGND
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,899,539 | 249,611 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $61,115,059 | 306,111 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $58,209,168 | 307,871 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $54,476,216 | 307,532 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $34,990,362 | 307,797 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $30,276,638 | 287,965 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $30,971,920 | 289,052 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $27,413,850 | 273,892 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $22,769,074 | 270,224 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $17,244,581 | 235,904 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $13,276,763 | 185,897 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,162,840 | 136,229 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $6,869,037 | 95,271 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,098,685 | 96,502 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,375,203 | 50,527 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,185,632 | 48,608 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,466,260 | 50,059 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $5,726,192 | 50,904 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,356 | 80 | Call | Defined | 2022-02-16 | |
| 2021-12-31 | $11,024,422 | 71,374 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $8,611,363 | 61,810 | Shares | Defined | 2021-11-04 | |
| 2021-09-30 | $20,897 | 150 | Call | Defined | 2021-11-04 | |
| 2021-06-30 | $9,852,105 | 75,098 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $12,635,811 | 82,885 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,460,505 | 85,073 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,015,456 | 84,090 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $2,287 | 24 | Call | Defined | 2020-11-12 | |
| 2020-06-30 | $11,411,378 | 102,024 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,979,294 | 95,975 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||